Company Profile

argenx (NASDAQ: ARGX)
5:00 PM UTC, 07/03/24
Last: $435.29 Change: -0.20 %Change: -0.05% Volume: 197,750
Detailed Quote
Open: $ 437.04   Volume: 197,750
High: $ 438.55   Yield(%) 0.00
Low: $ 433.35   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 25.88B
EPS ($) -1.06   Shares Out: 59.43M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 15.03
% Price Change (last 13 weeks): 9.66
% Price Change (last 26 weeks): 14.30
% Price Change (last 52 weeks): 14.13
% Price Change (year to date): 14.47
Management Effectiveness
Return on Equity (%): -8.55
Return on Assets (%): -7.70
Return on Invested Capital (%): -23.35
Profitability
Gross Profit Margin (%): 81.59
Net Profit Margin (%): -24.06
Operating Profit Margin (%): -36.78
Price & Volume
50-day Moving Average: $385.47
200-day Moving Average: $417.59
Avg. Daily Vol. (last 50 days): 303,047
Avg. Daily Vol. (last 200 days): 338,654
52-wk high: $550.76
52-wk low: $327.73
Bid: $423.91
Ask: $445.06
Company Information
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
argenx
Laarderhoogtweg 25
Amsterdam NH 1101 EB

Phone: 31.76.303.04.88
Fax: n/a
http://www.argen-x.com
Per Share Data
Earnings (1year) ($): -5.17
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 69.22
Cash Flow ($): -3.11
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 17.71
Price/Book (x): 5.50
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 9.01
Current Ratio (x): 9.75
LT Debt/Equity (x): 0.37
Total Debt/Equity (x): 0.49



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.